Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
11 |
13
|
2009 |
2019 |
Blood Pressure
|
phenotype |
|
Organism Function
|
109
|
220
|
0.100 |
None |
1.000 |
2 |
2
|
2011 |
2013 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
2 |
3
|
2017 |
2019 |
Diastolic blood pressure measurement
|
phenotype |
|
Diagnostic Procedure
|
35
|
81
|
0.100 |
None |
1.000 |
2 |
3
|
2009 |
2018 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Systolic blood pressure measurement
|
phenotype |
|
Diagnostic Procedure
|
54
|
95
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
response to bronchodilator
|
phenotype |
|
Organism Function
|
131
|
1106
|
0.100 |
None |
1.000 |
1 |
3
|
2015 |
2015 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
4
|
2018 |
2018 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.110 |
None |
1.000 |
2 |
2
|
2009 |
2017 |
Aortic Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
43
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Coronary heart disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1576
|
1178
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
acute aortic dissection
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
63
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Monoclonal Gammopathy of Undetermined Significance
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
227
|
20
|
0.100 |
None |
1.000 |
2 |
3
|
2015 |
2019 |
Paraproteinemias
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
9
|
0.100 |
None |
1.000 |
2 |
2
|
2015 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.330 |
None |
1.000 |
3 |
|
2014 |
2020 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Behavior Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
77
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |